论文信息 - A bioequivalence study of proposed bevacizumab biosimilar, MYL-1402O (A) vs EU-Avastin (B) and US-Avastin (C). - 字舞流文

A bioequivalence study of proposed bevacizumab biosimilar, MYL-1402O (A) vs EU-Avastin (B) and US-Avastin (C).

M. Socinski | M. Hummel | Andrew R Shaw | M. Liu | A. Barve | T. Bosje | Mark Baczkowski | E. Pennella | M. Kothekar